Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16329823 | 0.89 | ELANE (0.32) | ELANE | |
| SCHEMBL12309181 | 0.67 | ELANE (0.33) | ELANEKDM4EPOLBRAB9A | |
| SCHEMBL10212104 | 0.65 | ELANE (0.35) | ELANEKDM4EPOLBRAB9A | |
| SCHEMBL2705397 | 0.65 | LMNA (0.36) | ELANEKDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL13587131 | 0.64 | ELANE (0.31) | ELANE | |
| SCHEMBL14866999 | 0.64 | LMNA (0.32) | ELANE | |
| SCHEMBL10227005 | 0.63 | ELANE (0.34) | ELANEKDM4EPOLBRAB9A | |
| SCHEMBL21721367 | 0.63 | ELANE (0.37) | ELANEKDM4EPOLBRAB9AALDH1A1 | |
| SCHEMBL21791911 | 0.63 | ELANE (0.33) | ELANEKDM4EPOLBRAB9A | |
| SCHEMBL12920796 | 0.63 | ELANE (0.33) | ELANEKDM4EPOLBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10770665-B2 | Fluorinated dye compounds for organic solar cells | NEXT ENERGY TECHNOLOGY, INC. (US) | 2020-09-08 | — | — | US | disclosed |
| US-20180114930-A1 | FLUORINATED DYE COMPOUNDS FOR ORGANIC SOLAR CELLS | NEXT ENERGY TECHNOLOGIES, INC. (US) | 2018-04-26 | — | — | US | disclosed |
| US-8975235-B2 | Lysophosphatidic acid receptor antagonists | INTERMUNE, INC. (US) | 2015-03-10 | — | — | US | disclosed |
| US-20140213538-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | INTERMUNE, INC. | 2014-07-31 | — | — | US | disclosed |
| US-20140200215-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | INTERMUNE, INC. | 2014-07-17 | — | — | US | disclosed |
| US-20130072449-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | INTERMUNE, INC. (US) | 2013-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140213538-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | LPAR1, LPAR2, LPAR5 | ELANE 440/4885KDM4E 4418/4885POLB 4247/4885 |
| US-10770665-B2 | Fluorinated dye compounds for organic solar cells | OR10J3, EPCAM, KCNN2 | ELANE 2213/4885KDM4E 2632/4885POLB 3468/4885 |
| US-20130072449-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | LPAR1, LPAR2, LPAR5 | ELANE 440/4885KDM4E 4418/4885POLB 4247/4885 |
| US-20140200215-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | LPAR1, LPAR2, LPAR5 | ELANE 440/4885KDM4E 4418/4885POLB 4247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.